Acutus Medical, Inc.

AFIB Healthcare Medical Devices

In the quarter to December 2024, revenue grew 204.2%, EPS grew 95.9% and free cash flow grew 76.4%, each against the same quarter a year earlier. Revenue growth for three consecutive years, operating cash flow growth for three.

0.00 0.00 NaN
Market cap
$1.7M
P/E
0.0×
Fwd P/E
−0.5×
Dividend yield
—
F-score
3/9
Altman Z
−28.52
Beneish M
−2.49
Dividend safety
n/a
Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24
Piotroski F-Score
— — — 6 4 3 3 3
P/E ratio
— 0.00 0.00 0.00 0.00 0.00 0.00 0.00
P/S ratio
— 4.73 4.73 38.83 5.66 13.06 0.85 0.09
Altman Z-Score
— — — (0.35) (4.35) (3.18) (15.48) (28.51)
Altman Z″-Score (non-manufacturers)
— (31.23) (9.12) (2.87) (7.73) (4.43) (34.40) (66.67)
P/FCF ratio
— 0.00 0.00 0.00 0.00 0.00 0.00 0.00
P/Operating CF
— (1.11) (1.11) (13.62) (4.33) (2.35) (0.34) (0.44)
Beneish M-Score
— — — — — — — (2.49)
P/B ratio
— 0.00 0.00 2.60 0.92 0.53 0.00 0.00
Price to Tangible BV
— 0.00 0.00 3.02 1.10 0.54 0.00 0.00
EV/Sales
— 7.20 7.20 28.05 2.18 (0.62) 1.56 1.01
EV/EBITDA
— 0.00 0.00 0.00 0.00 0.00 0.00 10.86
EV/Operating CF
— (0.42) (0.42) (2.79) (0.38) 0.02 (0.18) (0.64)
EV/FCF
— (0.38) (0.38) (2.46) (0.34) 0.02 (0.18) (0.64)
Quick Ratio
— 0.73 2.26 6.09 5.65 4.74 2.15 1.76
Current Ratio
— 0.88 2.58 6.91 6.82 5.93 2.44 2.06
Net Debt/EBITDA
— (0.25) 0.63 1.06 0.59 (0.75) (0.43) 9.90
Debt/Assets
0.00% 99.68% 37.06% 20.75% 24.04% 26.04% 63.97% 113.69%
Debt/Equity
— (1.92) 1.42 0.32 0.39 0.46 (39.27) (2.81)
Asset Turnover
— 0.17 0.04 0.06 0.10 0.02 0.08 0.49
Operating CF/Net income
— 0.71 0.58 0.84 0.85 2.24 0.77 3.32
Capex/Depreciation
— (0.38) (0.65) (2.18) (1.04) (0.02) (12.88) (0.06)
Interest Coverage
— (7.22) (3.26) (16.59) (19.75) 7.97 (2.07) (0.01)
ROE
— 26.79% 54.27% 205.55% (101.32%) (43.84%) (220.29%) 153.11%
ROA
— (369.25%) (147.70%) (68.45%) (64.96%) (26.13%) (87.15%) (23.11%)
ROIC
— 0.00% 0.00% (161.69%) (153.63%) 76.43% (174.27%) (0.51%)
Return on Tangible Assets
— (4,795.50%) (176.52%) (71.90%) (96.90%) (39.75%) (290.25%) (69.91%)
Average Days of Receivables
— 27.64 33.85 93.15 76.81 2,157.85 578.43 142.65
Research and Development Expense of Revenue
— 880.75% 812.02% 395.25% 212.49% 102.87% 48.60% 0.00%
Selling, General and Administrative Expense of Revenue
— 615.42% 946.65% 594.96% 367.97% 670.24% 196.34% 51.77%
Intangible Assets out of Total Assets
0.00 0.00 0.15 0.09 0.10 0.00 0.00 0.00
Share Based Compensation of Revenue
— 95.61% 105.57% 142.99% 79.67% 112.17% 42.32% 2.28%
Graham Net Nets
— (1.52) (1.52) 0.26 0.64 1.50 (1.41) (8.21)
Graham Number
— 0.00 1,044.88 0.00 0.00 0.00 1.38 1.69
Earnings Yield
— (507.09%) (507.09%) (211.93%) (120.82%) (104.32%) (1,335.95%) (545.33%)
Free Cash Flow Yield
— (399.86%) (399.86%) (29.33%) (112.22%) (225.26%) (1,036.62%) (1,778.87%)
Revenue per Share
— 3.97 4.22 0.74 0.60 0.11 0.25 0.68
Operating CF per Share
— (61.89) (83.31) (7.47) (3.48) (3.12) (2.17) (1.06)
Capex per Share
— (3.73) (19.93) (0.98) (0.35) (0.01) (0.01) 0.00
Free Cash Flow per Share
— (65.62) (103.25) (8.45) (3.83) (3.13) (2.18) (1.07)
Cash per Share
— 32.79 107.07 11.50 3.52 2.68 1.01 0.47
Shareholders Equity per Share
— (24.74) 40.99 11.10 3.69 2.63 (0.03) (0.39)
Interest Debt per Share
— 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
— (24.74) 40.99 11.10 3.69 2.63 (0.03) (0.39)
Free Cash Flow
— (35.82) (69.38) (96.39) (109.65) (89.14) (63.34) (31.77)
Working Capital
— (2.92) 50.55 129.48 107.78 98.00 27.31 13.14
Capital Expenditures
— (2.04) (13.39) (11.22) (9.97) (0.23) (0.22) (0.11)
Net Current Asset Value
— (17.51) 4.55 85.44 62.22 59.45 (8.59) (14.66)
EV/EBIT
— 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capex to Sales
— 0.94 4.72 1.33 0.58 0.08 0.03 0.01
Price to Operating Income
— 0.00 0.00 0.00 0.00 0.96 0.00 0.00
Other line items
Depreciation/Fixed assets
— 1.36 4.65 0.42 0.70 8.42 0.02 3.73
Cash ROIC
— (118.39%) (50.07%) (32.37%) (44.31%) (47.93%) (100.42%) (90.79%)
Accounts Receivable Turnover
— 10.15 13.28 6.99 5.96 0.28 0.49 2.10
Accounts Payable Turnover
— 2.74 3.37 2.62 4.17 0.99 3.94 9.48
Inventory Turnover
— 1.31 1.62 1.49 2.24 0.54 3.39 6.31
Average Days of Payables
— 77.62 153.30 189.89 83.35 182.68 97.83 24.33
Days of Inventory on Hand
— 145.95 332.66 297.67 181.90 132.53 151.58 34.13
Average Receivables
— 0.21 0.21 1.21 2.90 10.78 14.64 9.62
Average Payables
— 2.74 2.74 6.07 7.89 5.00 2.62 2.02
Average Inventory
— 5.71 5.71 10.69 14.68 9.10 3.04 3.03
Average Assets
— 12.97 65.70 149.00 181.16 151.62 93.70 41.30
Average Common Equity
— (178.82) (178.82) (49.61) 116.15 90.37 37.07 (6.24)

Fold the line items

Columns are period end dates